Hepion Pharmaceuticals
(NASDAQ:HEPA)
$2.85
0.09[3.26%]
Last update: 8:46AM Get Real Time Here

GET A REPORT ON HEPA SENT RIGHT TO YOUR INBOX

Hepion Pharmaceuticals Stock (NASDAQ:HEPA), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.
Consensus Rating1
Overweight
Highest Price Target1
$0.00
Lowest Price Target1
$0.00
Consensus Price Target1
$1.75

Analyst Rating Summary1

Analyst Ratings
Dec 23
0
0
0
0
0
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Brookline Capital
Cantor Fitzgerald

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Hepion Pharmaceuticals

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
12/07/2023HEPABuy Now
Hepion Pharmaceuticals
$2.85Brookline Capital
Kumaraguru Raja
DowngradeBuy → HoldGet Alert
02/28/2022HEPABuy Now
Hepion Pharmaceuticals
$2.8522.81%Cantor Fitzgerald
Kristen Kluska
→ $70Initiates → OverweightGet Alert

FAQ

Q

What is the target price for Hepion Pharmaceuticals (HEPA)?

A

The latest price target for Hepion Pharmaceuticals (NASDAQ: HEPA) was reported by Brookline Capital on December 7, 2023. The analyst firm set a price target for $0.00 expecting HEPA to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Hepion Pharmaceuticals (HEPA)?

A

The latest analyst rating for Hepion Pharmaceuticals (NASDAQ: HEPA) was provided by Brookline Capital, and Hepion Pharmaceuticals downgraded their hold rating.

Q

When is the next analyst rating going to be posted or updated for Hepion Pharmaceuticals (HEPA)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Hepion Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Hepion Pharmaceuticals was filed on December 7, 2023 so you should expect the next rating to be made available sometime around December 7, 2024.

Q

Is the Analyst Rating Hepion Pharmaceuticals (HEPA) correct?

A

While ratings are subjective and will change, the latest Hepion Pharmaceuticals (HEPA) rating was a downgraded with a price target of $0.00 to $0.00. The current price Hepion Pharmaceuticals (HEPA) is trading at is $2.85, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch